Search for content, post, videos

A buy signal for these stocks: EQT Corporation (NYSE:EQT), Sunedison Inc (NYSE:SUNE), Clovis Oncology Inc (NASDAQ:CLVS)

Relative Strength Index or RSI is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine overbought and oversold conditions of an asset. A trader using RSI should be aware that large surges and drops in the price of an asset will affect the RSI by creating false buy or sell signals. The RSI is best used as a valuable complement to other stock-picking tools. The RSI ranges from 0 to 100. An asset is deemed to be overbought once the RSI approaches the 70 level, meaning that it may be getting overvalued and is a good candidate for a pullback. Likewise, if the RSI approaches 30, it is an indication that the asset may be getting oversold and therefore likely to become undervalued.

EQT Corporation (NYSE:EQT) is now in oversold territory with an RSI value of 28.83. The stock is down -13.88% in one month through last close, to $ 58.81, showing a -17.05% return during the past three months. The share price is up from fifty two week low with -0.49% and low from fifty two week high with -40.01%. It stands – 15.40% below the average-price of 50 days and -9.27% compared with the SMA 20.

Sunedison Inc (NYSE:SUNE) has a RSI reading of 24.25, with a 1-year total return of -87.25% and a six-month return of -90.69%. The stock is down -63.85% in one month through last close, to $2.82, showing a -73.72% return during the past three months. The share price is up from fifty two week low with 4.06% and low from fifty two week high with -91.57%. It stands -65.04% below the average-price of 50 days and -55.27% compared with the SMA 20.

Clovis Oncology Inc (NASDAQ:CLVS) currently has an RSI of 14.89. The stock is down -71.68% in one month through last close, to $26.41, showing a -60.59% return during the past three months. The share price is up from fifty two week low with 1.93% and low from fifty two week high with -77.83%. It stands -71.59% below the average-price of 50 days and -69.63% compared with the SMA 20.